Multiple Myeloma Refractory study: Target trough IgG level of vs Target trough IgG level
Official title Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
ClinicalTrials.gov ID: NCT07094048
What this study is testing
What is Target trough IgG level of 8-10 g/L?
Target trough IgG level of 8-10 g/L is an investigational medicine, being studied as a potential treatment for multiple myeloma refractory.
Also referred to as Standard of care.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to find out if giving immunoglobulins (immune protein shots) reduces the risk of infections in patients with multiple myeloma who are receiving BCMA-targeted treatments.
- Who it's for
- The study is looking for adults with relapsed or refractory multiple myeloma who are currently receiving a BCMA-directed T cell engager therapy.
- What's involved
- Participants will receive immunoglobulin infusions and be monitored for signs of infection while continuing their standard myeloma treatment.
- Time commitment
- The source text does not specify the total duration of the study or the required visit schedule.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- ≥ 18 years old
- ≥ 1 prior lines of therapy
- Receiving a BCMA-directed T-cell Engager therapy (starting on treatment)
- On previous Ig support or not
You likely can't join if
- Less than 18 years old
- Pregancy or breastfeeding
The study team makes the final eligibility decision.
Where it is enrolling
- Lévis, Quebec, Canada
- Montreal, Quebec, Canada
- Québec, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Lévis, Quebec, Canada; Montreal, Quebec, Canada; Québec, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.